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Aims:
•The cloning, expression, purification and characterisation of recombinant
prokaryotic glycolytic enzymes
•The mutagenesis of prokaryotic glycolytic enzymes to generate novel
recombinant carbohydrate binding proteins
•The characterisation of the binding profile of the novel recombinant
carbohydrate binding proteins
6. Future Work
• Enable detection of chb mutant in ELLAs – use of linker, longer His tag
or biotinylation
• Further characterization of binding once detection is enabled
• Random mutagenesis to alter binding specificities/affinities
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1. Intro:
The overall objective of this project is to generate novel carbohydrate binding
proteins for use in glycoprotein analysis which are amenable to large scale
production. The approach used here is the modification of prokaryotic
glycolytic enzymes. The enzymes being studied are from Photorhabdus
luminescens and are chitobiases (chb) which are a subset of glycolytic
enzymes. These enzymes recognize and cleave N-Acetylglucosamine
(GlcNAc) dimers to GlcNAc monomers.
We will eliminate their enzymatic activity while hoping they still retain their
binding capabilities. The resulting novel carbohydrate binding proteins will
have huge commercial potential in the field of glycoanalysis.
Figure 1: A chitobiase from Serratia
marcescens. A chb from Serratia
marcescens has already been cloned
and purified. Its catalytic activity has
been removed and it has been
shown to bind glycans in solution
[Tews et al 1996, Prag et al 2000].
Our specific objective is to look at a
homologue of this chb from
Photorhabdus luminescens and use
the work on Serratia marcescens as
a guide.
2. Cloning, Expression and Purification of a chb from P.
luminescens
Figure 2: a) Construct map. Chb PCR product (yellow) was inserted into a
pQE60 vector as an NcoI-BamHI fragment. This vector adds a C terminal His
tag (red) to its product. The vector also contains ampicillin resistance (blue) for
selection. This product was subsequently transformed into Escherichia coli
XL10Gold for expression. b) Samples from E. coli cultures containing the
expression vectors were taken every hour for 5 hours and lysed by sonication.
SDS-PAGE was used to examine expression of chb c) IMAC purification of chb
a) b) c)
4. Generation of a novel non-
hydrolytic chb carbohydrate-
binding protein.
Activity of chb compared with it's commercial counterpart
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3. Enzymatic activity of the
chb chitobiase compared
with commercial counterpart
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Lectin
Binding of P. luminescens chb mutant to GlcNAc residues
5. ELLA analysis detects binding of chb mutant to GlcNAc
residues
b)a)
Figure 5: a) ELLA used to detect binding to GLcNAc residues using GSLII
as a positive control and ECL as a negative control. No binding by chb
mutant to GlcNAc residues was detected however this could be due to an
inability to detect a signal rather than no binding occurring. b) Competitive
assay using a constant concentration of GSLII with an increasing
concentration of chb mutant. Indirectly shows that chb mutant is binding to
GlcNAc residues.
Poster presentations
•School of Biotechnology Research Day, DCU, January 2011
•ISSC Review Meeting, DCU, June 2010
• 3rd Annual Meeting of Glycoscience Ireland, UCD, August 2010.
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Figure 4: Mutagenesis of
recombinant chb results in
abolition of catalytic activity.
Figure 3: Colorimetric Assay to
test activity of chb enzyme. The
substrate 4-Nitrophenol N-acetyl β
D glucosaminide is cleaved by the
enzyme to release a coloured
compound which can be detected.
Oral Presentations
• School of Biotechnology Seminar Series, DCU, April 2011
